SLT Holdings LLC purchased a new position in Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU – Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 5,000 shares of the company’s stock, valued at approximately $797,000. SLT Holdings LLC owned about 0.14% of Direxion Daily S&P Biotech Bull 3x Shares as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. Great Hill Capital LLC purchased a new position in shares of Direxion Daily S&P Biotech Bull 3x Shares in the 3rd quarter worth about $688,000. JPMorgan Chase & Co. purchased a new position in shares of Direxion Daily S&P Biotech Bull 3x Shares in the 3rd quarter worth about $3,208,000. IvyRock Asset Management HK Ltd purchased a new position in shares of Direxion Daily S&P Biotech Bull 3x Shares in the 3rd quarter worth about $768,000. IMC Chicago LLC purchased a new position in shares of Direxion Daily S&P Biotech Bull 3x Shares in the 3rd quarter worth about $3,806,000. Finally, Millennium Capital Advisors LLC purchased a new position in shares of Direxion Daily S&P Biotech Bull 3x Shares in the 4th quarter worth about $648,000.
Direxion Daily S&P Biotech Bull 3x Shares Price Performance
Shares of NYSEARCA:LABU opened at $175.19 on Monday. The company’s 50-day moving average is $174.28 and its 200 day moving average is $165.47. Direxion Daily S&P Biotech Bull 3x Shares has a fifty-two week low of $48.10 and a fifty-two week high of $212.45.
Direxion Daily S&P Biotech Bull 3x Shares Profile
The Direxion Daily S&P Biotech Bull 3X Shares (LABU) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times exposure to the S&P Biotechnology Select Industry Index. LABU was launched on May 28, 2015 and is managed by Direxion.
See Also
- Five stocks we like better than Direxion Daily S&P Biotech Bull 3x Shares
- The Smart Glasses Gold Rush Is Leaving Old-School Eyewear Behind
- 3 Rare Earth Stocks That Win No Matter What China Does Next
- Amylyx Stock: Why the Full Pipeline Story Matters
- Palantir and Dell Build an AI OS for the Paranoid
Receive News & Ratings for Direxion Daily S&P Biotech Bull 3x Shares Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Direxion Daily S&P Biotech Bull 3x Shares and related companies with MarketBeat.com's FREE daily email newsletter.
